Standard Chemical & Pharmaceutical Co Ltd (1720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Standard Chemical & Pharmaceutical Co Ltd (1720) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$510.55 Million ≈ $16.09 Million USD) by net assets (NT$9.02 Billion ≈ $284.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Standard Chemical & Pharmaceutical Co Lt to measure how much of total assets are equity-financed.

Standard Chemical & Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Standard Chemical & Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Standard Chemical & Pharmaceutical Co Lt to evaluate the quality of earnings relative to operating cash generation.

Standard Chemical & Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Standard Chemical & Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Qingdao Hi-Tech Moulds & Plastics Technology Co. Ltd. SHE:301022	0.051x
Chengdu Shengbang Seals Co.Ltd. SHE:301233	0.020x
EQT Holdings Ltd AU:EQT	0.045x
MT Hoejgaard Holding A/S CO:MTHH	-0.028x
Dear U Co. Ltd. KQ:376300	0.033x
Shanghai Mechanical & Electrical Industry Co Ltd B SHG:900925	-0.013x
TECHPOINT INC. JDR/1 F:R46	N/A
Air Asia Co Ltd TW:2630	0.161x

Annual Cash Flow Conversion Efficiency for Standard Chemical & Pharmaceutical Co Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Standard Chemical & Pharmaceutical Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Standard Chemical & Pharmaceutical Co Lt market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$8.98 Billion ≈ $282.80 Million	NT$1.69 Billion ≈ $53.40 Million	0.189x	+14.97%
2023-12-31	NT$8.14 Billion ≈ $256.37 Million	NT$1.34 Billion ≈ $42.11 Million	0.164x	-0.53%
2022-12-31	NT$7.44 Billion ≈ $234.26 Million	NT$1.23 Billion ≈ $38.68 Million	0.165x	+35.76%
2021-12-31	NT$6.80 Billion ≈ $214.23 Million	NT$827.03 Million ≈ $26.06 Million	0.122x	-35.32%
2020-12-31	NT$4.91 Billion ≈ $154.56 Million	NT$922.58 Million ≈ $29.07 Million	0.188x	+36.97%
2019-12-31	NT$4.65 Billion ≈ $146.39 Million	NT$637.94 Million ≈ $20.10 Million	0.137x	+20.22%
2018-12-31	NT$4.25 Billion ≈ $133.78 Million	NT$484.94 Million ≈ $15.28 Million	0.114x	-32.29%
2017-12-31	NT$4.20 Billion ≈ $132.39 Million	NT$708.74 Million ≈ $22.33 Million	0.169x	+131.78%
2016-12-31	NT$4.20 Billion ≈ $132.22 Million	NT$305.38 Million ≈ $9.62 Million	0.073x	-56.54%
2015-12-31	NT$3.89 Billion ≈ $122.46 Million	NT$650.87 Million ≈ $20.51 Million	0.167x	+3.69%
2014-12-31	NT$3.61 Billion ≈ $113.60 Million	NT$582.30 Million ≈ $18.35 Million	0.161x	+35.41%
2013-12-31	NT$3.58 Billion ≈ $112.87 Million	NT$427.26 Million ≈ $13.46 Million	0.119x	-1.97%
2012-12-31	NT$3.31 Billion ≈ $104.17 Million	NT$402.25 Million ≈ $12.67 Million	0.122x	-6.33%
2011-12-31	NT$3.12 Billion ≈ $98.36 Million	NT$405.49 Million ≈ $12.78 Million	0.130x	+38.92%
2010-12-31	NT$2.91 Billion ≈ $91.81 Million	NT$272.47 Million ≈ $8.58 Million	0.094x	-58.59%
2009-12-31	NT$2.81 Billion ≈ $88.50 Million	NT$634.23 Million ≈ $19.98 Million	0.226x	-18.22%
2008-12-31	NT$2.60 Billion ≈ $82.07 Million	NT$719.17 Million ≈ $22.66 Million	0.276x	+119.99%
2007-12-31	NT$2.58 Billion ≈ $81.23 Million	NT$323.60 Million ≈ $10.20 Million	0.126x	-9.88%
2006-12-31	NT$2.58 Billion ≈ $81.17 Million	NT$358.75 Million ≈ $11.30 Million	0.139x	-9.29%
2005-12-31	NT$2.42 Billion ≈ $76.09 Million	NT$370.77 Million ≈ $11.68 Million	0.154x	-17.69%
2004-12-31	NT$1.80 Billion ≈ $56.67 Million	NT$335.45 Million ≈ $10.57 Million	0.187x	+13.25%
2003-12-31	NT$1.66 Billion ≈ $52.21 Million	NT$272.89 Million ≈ $8.60 Million	0.165x	+75.71%
2002-12-31	NT$1.58 Billion ≈ $49.67 Million	NT$147.75 Million ≈ $4.66 Million	0.094x	--

About Standard Chemical & Pharmaceutical Co Ltd

TW:1720 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$319.22 Million

NT$10.13 Billion TWD

Market Cap Rank

#14358 Global

#584 in Taiwan

Share Price

NT$56.70

Change (1 day)

-1.39%

52-Week Range

NT$54.10 - NT$65.60

All Time High

NT$77.40